Latigo Biotherapeutics, Inc. Share Price
NASDAQ: LTGOLatigo Biotherapeutics, Inc. Stock Performance
Latigo Biotherapeutics, Inc. Share Price Today
As of 8 October 2026, Latigo Biotherapeutics, Inc.'s share price is $15.45. The stock opened at $15.63, compared to its previous close of $16.09. During today's trading session, Latigo Biotherapeutics, Inc.'s share price traded between $15.48 and $15.64, with an average price of $15.56. Over the past 52 weeks, the stock has recorded a high of $25.90 and a low of $15.48. In terms of performance, Latigo Biotherapeutics, Inc.'s share price has declined by 38.22% over the last six months and is down 38.22% on a year-on-year basis.
Latigo Biotherapeutics, Inc. Share Price Chart
About Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
Latigo Biotherapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $17.38 | $15.54 | -6.89% |
Sep 2026 | $21.55 | $16.69 | -33.27% |
Aug 2026 | $22.00 | $25.01 | N/A |